MACQUARIE GROUP LTD 13D and 13G filings for Ligand Pharmaceuticals Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-01 4:07 pm Sale |
2024-09-30 | 13G | Ligand Pharmaceuticals Incorporated LGND |
MACQUARIE GROUP LTD | 887,275 4.860% |
-99,973 (-10.13%) |
Filing |
| 2024-02-14 06:26 am Sale |
2023-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
MACQUARIE GROUP LTD | 987,248 5.660% |
-14,577 (-1.46%) |
Filing |
| 2022-02-14 10:39 am Sale |
2021-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
MACQUARIE GROUP LTD | 1,001,825 3.740% |
-462,760 (-31.60%) |
Filing |
| 2021-02-12 10:15 am Purchase |
2020-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
MACQUARIE GROUP LTD | 1,464,586 5.680% |
1,464,586 (New Position) |
Filing |